share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯維公司 | 144:擬議出售證券
美股SEC公告 ·  07/18 04:22

牛牛AI助理已提取核心訊息

Richard Gonzalez, an officer and director at AbbVie Inc., is set to sell 282,845 shares of the company's common stock on 07/17/2024, with an aggregate market value of approximately $49,497,875. The shares to be sold were acquired on the same date through a stock option exercise from the issuer, with cash payment. There is no recent sale history reported for Gonzalez in the past three months, as per the latest filings.
Richard Gonzalez, an officer and director at AbbVie Inc., is set to sell 282,845 shares of the company's common stock on 07/17/2024, with an aggregate market value of approximately $49,497,875. The shares to be sold were acquired on the same date through a stock option exercise from the issuer, with cash payment. There is no recent sale history reported for Gonzalez in the past three months, as per the latest filings.
AbbVie Inc.的一名官員兼董事Richard Gonzalez計劃於2024年07月17日賣出282,845股該公司普通股,預計市值約爲$49,497,875。這些股票將通過股票期權行權在同一日期從發行人處獲得並以現金支付。根據最新的文件披露,Gonzalez在過去三個月沒有報告任何最近的股票交易記錄。
AbbVie Inc.的一名官員兼董事Richard Gonzalez計劃於2024年07月17日賣出282,845股該公司普通股,預計市值約爲$49,497,875。這些股票將通過股票期權行權在同一日期從發行人處獲得並以現金支付。根據最新的文件披露,Gonzalez在過去三個月沒有報告任何最近的股票交易記錄。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。